Loading...
OSVP Webinar Series2019-03-13T11:07:15-06:00

IVI periodically hosts informational webinars on topics related to the Open-Source Value Project and IVI’s open-source value assessment models. Free and open to the public, our webinars are recorded and available to view on demand.

Upcoming Events

No upcoming webinars are currently scheduled, but please check back for future events.

Past Events

Note: The recorded webinar is available on demand. Once you register on the event page, the webinar will be immediately available to you. You can return to the event page at any time, click on the “Already Registered” link and enter your e-mail address to view the webinar again.

Advancing the Science of Value Assessment: New Open-Source Model for Non-Small Cell Lung Cancer

Original Air Date: February 25, 2019 at 3pm EST/12pm PST
Length: 60 minutes

This webinar introduces IVI’s new open-source value model focused on EGFR+ non-small cell lung cancer (NSCLC). Released February 1, public comment on the model and user interfaces is encouraged through April 1, 2019.

In this webinar, which is designed for all audiences, IVI’s team provides an overview of the model, how it generates customized data on different non-small cell lung cancer therapies and how these data-driven insights unlock value for healthcare stakeholders.

VIEW RECORDED WEBINAR

Modernizing Models for Value Assessment: A Detailed Discussion of the Open-Source IVI-NSCLC Model

Original Air Date: February 27, 2019 at 2:30pm EST/11:30am PST
Length: 90 minutes

This webinar, which is designed for technical audiences, showcases IVI’s new open-source value model focused on EGFR+ non-small cell lung cancer (NSCLC).

IVI’s team, led by Jeroen Jansen and Devin Incerti, present an overview to foster a deeper understanding of the entirety of the IVI-NSCLC model package. The presenters will walk you through the key components of the open-source model, how the IVI model generates customized information on EGFR+ NSCLC treatment sequences, and how to apply the information in assessing value in health care among different populations.

VIEW RECORDED WEBINAR

Measuring the Value of Health Care Treatments: Time for a New Approach

Original Air Date: December 12, 2017 at 4pm EST/1pm PST
Duration: 59 minutes

While different health care stakeholders have different perceptions of value, traditional value assessments are often “black boxes” that only account for a single perspective or a single population. For that reason, existing value frameworks tend to fall short for many individual stakeholders. The Open-Source Value Platform (OSVP) seeks to change that by creating flexible, transparent, iterative, and consensus-based modeling platforms for specific diseases.

IVI has recently released its model of value assessment for rheumatoid arthritis (RA). Join IVI for a webinar to better understand how the OSVP process works, learn about our first model in rheumatoid arthritis, and find out how you can get involved.

VIEW RECORDED WEBINAR

Creating Open-Source Models for Value Assessment: A Detailed Discussion of the IVI Rheumatoid Arthritis Model

Original Air Date: December 14, 2017 at 4pm EST/1pm PST
Duration: 59 minutes

Open-Source Value Platform (OSVP) models are built to be entirely open-source, allowing anyone to customize the tool depending on their own assumptions and understanding of value. IVI has released the source code, documentation, and suite of tools for its open-source model of value assessment for rheumatoid arthritis (RA) into the public domain. Our R package and highly customizable model interfaces allow experienced users to choose from over 300 different model structures, vary nearly all model inputs, and assess value using either cost-effectiveness or multi-criteria decision analytic approaches.

Are you interested in the technical and methodological aspects of the model? Join IVI for a webinar about the IVI-RA model and IVI’s open-source modeling approach. Presenters will walk you through the key components of the open-source consensus-based model, how the IVI model generates customized information on rheumatoid arthritis treatments, and how to apply the information in assessing value in health care.

VIEW RECORDED WEBINAR